Acute flaccid paralysis syndrome associated with West Nile virus infection - Mississippi and Louisiana, July-August 2002

Morbidity and Mortality Weekly Report

Volumn 51, Issue 37, 2002, Pages

  Leis, A ^a   Stokic, D ^a   Polk, J ^a   Dostrow, V ^a   Winkelman, M ^a   Webb, R ^c   Slavinski, S ^c   Currier, M ^c   Van Gerpen, J ^b   Brewer, E ^c   Ratard, R ^c   Sejvar, J ^c   Petersen, L ^c   Marfin, A ^c   Campbell, G ^c   Tierney, B ^c   Haddad, M ^c   Montgomery, S ^c   Vicari, A ^c  

^a METHODIST REHABILITATION CENTER   (United States)

^b OCHSNER CLINIC FOUNDATION   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0039435252     PISSN: 01492195     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Nash D, Mostashari F, Fine A, et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 2001; 344:1807-14.
2. Weiss D, Carr D, Kellachan J, et al. Clinical findings of West Nile virus infection in hospitalized patients, New York and New Jersey, 2000. Emerg Infect Dis 2001;7:654-7.
3. Asnis D, Conetta R, Teixeria A, Waldman G, Sampson B. The West Nile virus outbreak of 1999 in New York; the Flushing Hospital experience. Clin Infect Dis 2000; 30:413-18.
4. Ohry A, Karpin H, Yoeli D, Lazari A, Lerman Y. West Nile virus myelitis. Spinal Cord 2001;39:662-3.
5. Solomon T, Kneen R, Dung N, et al. Poliomyelitis-like illness due to Japanese encephalitis virus. Lancet 1998;351:1094-7.
6. Manuelidis E. Neuropathology of experimental West Nile infection in monkeys. J Neuropathol Exp Neurol 1956;15:448-60.
7. Gorson K, Ropper A. Nonpoliovirus poliomyelitis simulating Guillain-Barre Syndrome. Arch Neurol 2001;58:1460-4.
8. Visser L, Van der Meche F, Van Doorn P, et al. Guillain-Barre syndrome without sensory loss (acute motor neuronopathy): a subgroup with specific clinical, electrodiagnostic and laboratory features. Brain 1995;118:841-7.
9. Norda R, Berseus O, Stemayr B. Adverse events and problems in therapeutic hemapheresis: a report from the Swedish registry. Transfus Apheresis Sci 2001;25:33-41.
10. Stangel M, Muller M, Marx P. Adverse events during treatment with high-dose intravenous immunoglobulins for neurological disorders. Eur Neurol 1998;40:173-4.